Status:
TERMINATED
High-intensity Interval Training for Obese Individuals
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
New Mexico Inbre
Conditions:
Obesity
Insulin Resistance
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This proposal's objective is to investigate the effects of a high-intensity intermittent stair climbing program on insulin resistance in individuals with obesity and at risk of type 2 diabetes (T2D). ...
Detailed Description
Significance The obesity epidemic is a worldwide public health problem. Recent data indicate that over 650 million adults around the world (\~13%) are considered obese. Obesity is one of the major ris...
Eligibility Criteria
Inclusion
- 18-45 years,
- body mass index (BMI) equal or superior than 30 kg/m²;
- homeostasis model assessment for insulin resistance (HOMA-IR) ≥ 2.71,
- no fear of being totally submerged underwater for 2 to 10 seconds
- comfortable having blood taken from a forearm vein.
Exclusion
- smokers,
- currently taking any medications known to impact their metabolism or immune system,
- bleeding or blood clotting disorder,
- physical injury,
- physical limitations,
- diagnostic of T2D,
- currently under the active care of a physician for any condition that may interfere with their safety.
- cardiovascular conditions (cardiac, peripheral vascular, or cerebrovascular disease),
- diseases that prevent participation in a maximal effort test without physician clearance per the American College of Sports Medicine (ACSM) guidelines (2017).
- signs and symptoms of cardiovascular disease, at rest or during physical activity, which includes pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication; known heart murmur; or unusual fatigue or shortness of breath with usual activities.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 12 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04075799
Start Date
January 1 2022
End Date
May 12 2023
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fabiano Trigueiro Amorim
Albuquerque, New Mexico, United States, 87110